![\"Hammersmith](\"https:\/\/blogs.imperial.ac.uk\/doii-staff\/files\/2020\/02\/abt_1023552154959456536MTUyMTQ5Nw.jpg\")
<\/p>\n<\/p>\n
Congratulations to members of the Department who have recently had their research findings published. Here\u2019s our round-up of the latest publication successes.<\/strong><\/p>\n To ensure the quality and accuracy of the information published on this blog, we source our data directly from Symplectic. Our reports are generated on a monthly basis, which means there may be a delay in publicising some publications.<\/em><\/p>\n <\/p>\n Congratulations to members of the Department who have recently had their research findings published. Here\u2019s our round-up of the latest publication successes. To ensure the quality and accuracy of the information published on this blog, we source our data directly from Symplectic. Our reports are generated on a monthly basis, which means there may be […]<\/p>\n","protected":false},"author":1381,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[81],"tags":[9201],"class_list":["post-174","post","type-post","status-publish","format-standard","hentry","category-research","tag-publications"],"yoast_head":"\n
\n\n
\n Title<\/strong><\/td>\n Canonical journal title<\/strong><\/td>\n Publication type<\/strong><\/td>\n Authors OR Authors\/Contributors<\/strong><\/td>\n Publication date<\/strong><\/td>\n<\/tr>\n \n Authors’ Reply.<\/a><\/td>\n Journal of the American Society of Nephrology<\/em><\/td>\n Letter, Comment<\/td>\n Clarke CL, Prendecki M, McAdoo SP, Willicombe M<\/td>\n 29\/09\/2020<\/td>\n<\/tr>\n \n Critical role of WNK1 in MYC-dependent early mouse thymocyte development.<\/a><\/td>\n eLife<\/em><\/td>\n Journal Article<\/td>\n K\u00f6chl R, Vanes L, Llorian Sopena M, Chakravarty P, Hartweger H, Fountain K, White A, Cowan J, Anderson G, Tybulewicz VL<\/td>\n 14\/10\/2020<\/td>\n<\/tr>\n \n Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.<\/a><\/td>\n Blood<\/em><\/td>\n Journal Article<\/td>\n Agathangelidis A, Chatzidimitriou A, Gemenetzi K, Giudicelli V, Karypidou M, Plevova K, Davis ZA, Yan X-J, Jeromin S, Schneider C, Pedersen LB, Tschumper R, Sutton LA, Baliakas P, Scarf\u00f2 L, van Gastel EJ, Armand M, Tausch E, Biderman B, Baer C, Bagnara D, Navarro A, de Septenville A, Guido V, Mitterbauer-Hohendanner G, Dimovski A, Brieghel C, Lawless S, Meggendorfer M, Stranska K, Ritgen M, Facco M, Tresoldi C, Visentin A, Patriarca A, Catherwood M, Bonello L, Sudarikov A, Vanura K, Roumelioti M, Skuhrova Francova H, Moysiadis T, Veronese SM, Giannopoulos K, Mansouri L, Karan-Djurasevic T, Sandaltzopoulos R, B\u00f6d\u00f6r C, Fais F, Kater AP, Panovska-Stavridis I, Rossi D, Alshemmari S, Panagiotidis P, Costeas PA, Espinet B, Antic D, Foroni L, Montillo M, Trentin L, Stavroyianni N, Gaidano G, Francia di Celle P, Niemann CU, Campo E, Anagnostopoulos A, Pott C, Fischer K, Hallek M, Oscier DG, Stilgenbauer S, Haferlach C, Jelinek DF, Chiorazzi N, Pospisilova S, Lefranc M-P, Kossida S, Langerak AW, Belessi C, Davi F, Rosenquist R, Ghia P, Stamatopoulos K<\/td>\n 29\/09\/2020<\/td>\n<\/tr>\n \n Identification of genetic targets in acute myeloid leukaemia for designing targeted therapy.<\/a><\/td>\n British Journal of Haematology<\/em><\/td>\n Journal Article<\/td>\n Mason CC, Fiol CR, Baker MJ, Nadal-Melsio E, Yebra-Fernandez E, Bicalho L, Chowdhury A, Albert M, Reid AG, Claudiani S, Apperley JF, Khorashad JS<\/td>\n 06\/10\/2020<\/td>\n<\/tr>\n \n The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor.<\/a><\/td>\n Trials<\/em><\/td>\n Journal Article<\/td>\n Hinsley S, Walker K, Sherratt D, Bailey L, Reed S, Flanagan L, McKee S, Brudenell Straw F, Dawkins B, Meads D, Auner HW, Kaiser MF, Cook M, Brown S, Cook G, Myeloma UK Clinical Trials Network<\/td>\n 02\/10\/2020<\/td>\n<\/tr>\n \n Technical considerations when designing a gene expression panel for renal transplant diagnosis<\/a><\/td>\n Scientific Reports<\/em><\/td>\n Journal Article<\/td>\n F. Toulza, K. Dominy, T. Cook, J. Galliford, J. Beadle, A. McLean & C. Roufosse<\/td>\n 21\/10\/2020<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"